Adverum Biotechnologies (ADVM) Misses Q1 EPS by 225c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q1 EPS of ($2.25).

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• Evercore: SpaceX prepares for first orbital Starship flight, faces power crisis
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics